# Interscope, Inc.

> Interscope, Inc. is a Northbridge, Massachusetts medical device company that develops the EndoRotor, a flexible, powered endoscopic resection system that dissects, resects, and collects tissue in the gastrointestinal tract without thermal energy. Founded in 2011, the company created the first flexible microdebrider designed for the digestive tract and holds the first and only FDA marketing authorization for Direct Endoscopic Necrosectomy (DEN) in walled-off pancreatic necrosis. Interscope sells to interventional gastroenterologists and hospitals, and distributes the EndoRotor system through a partnership with Micro-Tech Endoscopy.

- **Founded:** 2011
- **Headquarters:** Northbridge, Massachusetts, United States
- **Founders:** Jeffery Ryan, Jr. (Co-Founder, President & CEO), Ramon A. Franco, Jr., MD (Co-Founder & Chief Scientific Officer)
- **Team size:** 14 employees
- **Products:** EndoRotor System, EndoRotor for Direct Endoscopic Necrosectomy (DEN), EndoRotor for Interventional Pulmonology, EndoRotor XT, EndoRotor University
- **Notable:** Created the first flexible microdebrider designed for use in the digestive tract., First and only device with FDA marketing authorization for Direct Endoscopic Necrosectomy (DEN) in walled-off pancreatic necrosis., FDA De Novo marketing authorization granted in December 2020.

## Products & services

- **EndoRotor System** — A flexible, powered endoscopic resection platform that performs tissue dissection, resection, and retrieval in a single step without thermal energy. A 3-in-1 tool combining resection (cutting), retraction (suction), and sampling/retrieval.
- **EndoRotor for Direct Endoscopic Necrosectomy (DEN)** — FDA De Novo authorized indication for minimally invasive treatment of walled-off pancreatic necrosis and infected pseudocysts.
- **EndoRotor for Interventional Pulmonology** — FDA-cleared indication for airway/pulmonary procedures performed without thermal energy risks.
- **EndoRotor XT** — Next-generation EndoRotor catheter for endoscopic powered resection.
- **EndoRotor University** — Educational and physician training program supporting EndoRotor procedures and clinical adoption.

## Achievements

- Created the first flexible microdebrider designed for use in the digestive tract.
- First and only device with FDA marketing authorization for Direct Endoscopic Necrosectomy (DEN) in walled-off pancreatic necrosis.
- FDA De Novo marketing authorization granted in December 2020.
- FDA clearance for interventional gastroenterology (2017) and interventional pulmonology (2019).
- CE Mark and European regulatory approval (2016) plus five U.S. patents.
- IDE trial of 30 patients: average of two procedures to complete necrosectomy with no device-related complications; ~16-day hospital stay vs. ~32 days in the literature.
- ISO 13485 certified.

## Latest updates

- **2020-12** — Interscope and Micro-Tech Endoscopy announced a partnership to distribute the EndoRotor System for interventional gastroenterology.
- **2020-12** — FDA De Novo marketing authorization granted for the EndoRotor System for Direct Endoscopic Necrosectomy.
- **2019-12** — EndoRotor received FDA clearance for interventional pulmonology indications.

## Links

- Website: https://interscopemed.com
- LinkedIn: http://www.linkedin.com/company/interscopemedical
- Twitter/X: https://twitter.com/interscopemed

---

Profile page: https://yespress.io/interscope-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-20